Skip to search formSkip to main content

cytomegalovirus immune globulin, intravenous

Known as: CMVIG 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cytomegalovirus immune globulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
Intravenous ganciclovir and, increasingly, oral valganciclovir are now considered the mainstay of treatment for cytomegalovirus… Expand
  • table 1
  • table 2
Is this relevant?
Review
2016
Review
2016
Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation
Cytomegalovirus (CMV) infection negatively influences both short- and long-term outcomes after cardiothoracic transplantation. In… Expand
  • table 1
Is this relevant?
2011
2011
The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database.
The association between cytomegalovirus immunoglobulin (CMVIG) and long-term clinical outcomes in heart transplantation has not… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
OBJECTIVE The goal of this meta-analysis was to investigate the impact of cytomegalovirus hyperimmune globulin (CMVIG) on… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
BACKGROUND Anticytomegalovirus (CMV) prophylaxis prevents the acute disease but its impact on subclinical infection and allograft… Expand
Is this relevant?
2001
2001
Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus…
BACKGROUND Cytomegalovirus (CMV) disease was previously shown to be unaltered by a 28-day course of ganciclovir compared with… Expand
Is this relevant?
Review
2000
Review
2000
Management of cytomegalovirus infection after liver transplantation.
Abstract Cyromegalovirus (CMV) is a ubiquitous herpesvirus that, together with human herpesvirus type 6 (HHV- 6) and HHV- 7… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam…
PURPOSE To assess impact of cytomegalovirus (CMV) donor-recipient serostatus, infection, or disease on development of invasive… Expand
Is this relevant?
1997
1997
Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Cytomegalovirus (CMV) causes considerable morbidity and mortality in orthotopic liver transplant (OLT) recipients. Several… Expand
Is this relevant?
1995
1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates.
We undertook a randomized, placebo-controlled, double blind trial of cytomegalovirus (CMV) immunoglobulin (CMVIG) for prevention… Expand
Is this relevant?